Zoledronic Acid for Treatment of Osteopenia and Osteoporosis in Women with Primary Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy

BACKGROUND: Postmenopausal women with osteoporosis/osteopenia are at increased risk of fracture. Aromatase inhibitors further increase bone loss in these patients. This study evaluates whether zoledronic acid prevents the bone loss expected when these patients initiate letrozole. PATIENTS AND METHOD...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hines, Stephanie L., Sloan, Jeff A., Atherton, Pamela J., Perez, Edith A., Dakhil, Shaker R., Johnson, David B., Reddy, Pavan S., Dalton, Robert J., Mattar, Bassam I., Loprinzi, Charles L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2010
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2854212/
https://ncbi.nlm.nih.gov/pubmed/20079640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2009.12.001
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi